American association of clinical endocrinologists' position statement on obesity and obesity medicine

Endocrine Practice

Volumn 18, Issue 5, 2012, Pages 642-648

  Mechanick, Jeffrey I ^a   Garber, Alan J ^a   Handelsman, Yehuda ^a   Garvey, W Timothy ^a  

^a American Association of Clinical Endocrinologists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARIATRIC SURGERY; BODY MASS; CERTIFICATION; HEALTH CARE ORGANIZATION; HUMAN; LIFESTYLE MODIFICATION; MEDICAL EDUCATION; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; OVARY POLYCYSTIC DISEASE; SLEEP DISORDERED BREATHING; SOCIAL CHANGE;

ENDOCRINOLOGY; HUMANS; OBESITY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84867339689     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12160.PS     Document Type: Article

References (20)

1. AACE/ACE Obesity Task Force. AACE/ACE Position Statement on the Prevention, Diagnosis, and Treatment of Obesity. Endocr Pract. 1998;4:297-350.
2. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: A white paper on evidence and arguments com-missioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008;16:1161-1177.
3. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Intern J Obes. 2004;28:34-38.
4. American Medical Association. Report 4 of the Council on Scientific Affairs (A-05). Recommendations for Physician and Community Collaboration on the Management of Obesity (Resolution 421, A-04), 2005.
5. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33:289-295.
6. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mor-Tality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183:E1059-E1066.
7. Speliotes EK, Wilier CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associ-Ated with body mass index. Nat Genet. 2010;42:937-948.
8. Saxena R, Elbers CC, Guo Y, et al. Large-scale gene-centric meta-Analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012:990:410-425.
9. Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121:21-33.
10. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003; 289:187-193.
11. Peeters A, Barendregt JJ, Willekens F, Mackeback JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: A life-Table analysis. Ann Intern Med. 2003;138:24-38.
12. Knowler WC, Barret-Connor E, Fowler SE, et al The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med. 2002;346: 393-403.
13. Pan XR, Li GW, Hu YH, et al. Effects of diet and exer-cise in preventing NIDDM in people with impaired glu-cose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care.1997;20:537-544.
14. Tuomilehto J, Lindström J, Eriksson JG, et al Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344: 1343-1350.
15. Ratner R, Goldberg R, Haffner S, et al Diabetes Prevention Program Research Group. Impact of inten-sive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care. 2005;28:888-894.
16. Torgerson JS, Hauptman J, Bodrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients (Erratum in Diabetes Care. 2004;27:856). Diabetes Care. 2004;27:155-161.
17. Garvey WT, Ryan DH, Look M, et al. Two-year sus-Tained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95:297-308.
18. Sjöström L, Lindroos AK, Peltonen M, et al Swedish Obese Subjects Study Scientific Group. Lifestyle, diabe-Tes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
19. Staman J. Obesity Discrimination and the Americans with Disabilities Act [2007]. Congressional Research Service (CRS) Reports and Issue Briefs. Paper 26. http://digi-Talcommons.ilr.cornefl.edU/Cr. Accessed on February 18, 2012.
20. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-1576.